27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
Half of the executives in our survey expect to do more deals if there's a downturn in 2020 than if t...
Read More >
The West Virginia Department of Environmental Protection is proposing to modify the General WV/Natio...
Read More >
As Hurricane Dorian, the first hurricane of the 2019 Atlantic season, bears down on Florida, the app...
Read More >
In a recent article published in The New York Times, Jason Dana, a professor at the Yale School of M...
Read More >
Pay equity challenges continue to make the news in the healthcare setting, primarily in the context ...
Read More >
Here’s to hoping all our readers have a great New Year’s, but do not forget that the Department of...
Read More >